Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Totilac vs Voluven in CABG Patients
NCT01654653Phase 4Completed
- Sponsor
- Innogene Kalbiotech
- Start
- Jul 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hypertonic sodium lactate in coronary heart disease (CHD), sponsored by Innogene Kalbiotech. Started Jul 2008; status: completed.
02
Drugs
hypertonic sodium lactate
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT01654653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654653.